Target intelligence / Profile preview

Luminal water in the gastrointestinal tract (GI luminal water)

Target
GI luminal water
Molecular classification
Other
01

Overview

Luminal water in the gastrointestinal tract refers to the volume of fluid maintained within the lumen of the stomach, small intestine, and colon. It is not a single molecular target like a protein or enzyme, but rather a physiological compartment whose volume is tightly regulated by the balance of fluid secretion and absorption across the intestinal epithelium (Hoad et al., 2007, Physics in Medicine & Biology). This fluid is essential for the enzymatic breakdown of food, the solubilization of nutrients for absorption, and the maintenance of stool consistency to facilitate transit. In clinical practice and drug development, luminal water is a key physiological parameter used to evaluate the efficacy of gastrointestinal drugs. Osmotic laxatives and secretagogues, such as linaclotide, increase luminal water to treat constipation by promoting bowel movements (Marciani et al., 2010, Gastroenterology). Conversely, anti-diarrheal medications like loperamide work to reduce luminal water by increasing transit time and promoting absorption. Modern imaging techniques, particularly Magnetic Resonance Imaging (MRI), allow for the non-invasive quantification of small bowel and colonic water content as a biomarker for drug action and disease states (Gunn et al., 2016, Alimentary Pharmacology & Therapeutics).

Other names
Gastrointestinal water contentIntraluminal fluidSmall bowel water content (SBWC)Colonic water content (CWC)Intestinal fluid volume
02

Mechanism of action

Drugs modulate luminal water volume by creating osmotic gradients (osmotic laxatives), stimulating active ion secretion (secretagogues targeting CFTR or ClC-2), or inhibiting ion absorption (NHE3 inhibitors), which leads to passive water movement into or out of the gastrointestinal lumen.

03

Biological functions

Nutrient digestionSolubilization of nutrientsLubrication of luminal contentsWaste transportOsmotic balanceElectrolyte homeostasis
04

Disease associations

ConstipationDiarrheaIrritable bowel syndrome (IBS)Inflammatory bowel disease (IBD)Malabsorption
05

Safety considerations

DehydrationElectrolyte imbalance (e.g., hypokalemia, hyponatremia)Abdominal distensionCrampingMalabsorption of co-administered medications
06

Interacting drugs

Polyethylene glycol

7 more in the full profile.

07

Biomarkers

Small bowel water content (SBWC) via MRIColonic water content (CWC) via MRIBristol Stool ScaleStool water percentage

Beyond the preview

Go deeper on Luminal water in the gastrointestinal tract (GI luminal water).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Luminal water in the gastrointestinal tract (GI luminal water).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call